ANRS Prévenir: Risk for PrEP Discontinuation Highest Among Younger MSM With Less Education

IDWeek 2019; October 2-6, 2019; Washington, DC
21st International Workshop on Co-morbidities and Adverse Drug Reactions in HIV; November 5-6, 2019; Basel, Switzerland
17th European AIDS Conference; November 6-9, 2019; Basel, Switzerland
MSM who were younger, new users of PrEP, and those with lower educational levels were at higher risk of PrEP discontinuation.
Format: Microsoft PowerPoint (.ppt)
File Size: 166 KB
Released: November 19, 2019

Acknowledgements

Provided by USF Health

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences
ViiV Healthcare

Related Content

Dr. Darrell Tan on what healthcare professionals in Canada need to know in order to combat PrEP-related stigma, from Clinical Care Options (CCO)

Darrell H. S. Tan, MD, FRCPC, PhD Released: November 19, 2021

Free slides from CCO featuring data on racial inequities in HIV care in BIPOC communities and strategies to combat racial disparities in HIV

person default Samantha V. Hill, MD, MPH David Malebranche, MD, MPH Released: November 19, 2021

Personal perspectives on the decision to take HIV PrEP, how it fits into the daily routine, and future long-acting options, from Clinical Care Options (CCO)

person default Christian R. Pollard (Patient) Released: November 10, 2021

Babafemi Taiwo, MBBS, discusses the importance of 2-drug regimens in HIV care for 2022 and beyond in this commentary from Clinical Care Options (CCO)

Babafemi Taiwo, MBBS Released: November 5, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue